Lactiga™ is a biotherapeutics company that developed and patented a new biologic, LCTG-001, to prevent mucosal infections. LCTG-001 is for patients with Primary Immunodeficiency Diseases (PIDD) including Selective IgA Deficiency (SIgAD) and Common Variable Immunodeficiency (CVID).Our goal is to help tens of millions of immunodeficient and immunocompromised people around the world experience normal lives, free from invasive t...
Lactiga™ is a biotherapeutics company that developed and patented a new biologic, LCTG-001, to prevent mucosal infections. LCTG-001 is for patients with Primary Immunodeficiency Diseases (PIDD) including Selective IgA Deficiency (SIgAD) and Common Variable Immunodeficiency (CVID).Our goal is to help tens of millions of immunodeficient and immunocompromised people around the world experience normal lives, free from invasive treatments.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.